TJX

TJX Operating Cash Flow (Statement)

$8.03BTTM · USD

Period ending:

TJX FY Cash from OperationsUSD
TJX FY Cash from Operations1990-01-31: $87.30M1991-01-31: $127.60M1992-01-31: $105.60M1993-01-31: $138.60M1994-01-31: $84.40M1995-01-31: $104.50M1996-01-31: $184.30M1997-01-31: $713.80M1998-01-31: $440.00M1999-01-31: $642.80M2000-01-31: $577.97M2001-01-31: $556.76M2002-01-31: $912.45M2003-01-31: $908.56M2004-01-31: $770.50M2005-01-31: $1.08B2006-01-31: $1.16B2007-01-31: $1.20B2008-01-31: $1.36B2009-01-31: $1.15B2010-01-31: $2.27B2011-01-31: $1.98B2012-01-31: $1.92B2013-01-31: $3.05B2014-01-31: $2.59B2015-01-31: $3.01B2016-01-31: $2.96B2017-01-31: $3.63B2018-01-31: $3.03B2019-01-31: $4.09B2020-01-31: $4.07B2021-01-31: $4.56B2022-01-31: $3.06B2023-01-31: $4.08B2024-01-31: $6.06B2025-01-31: $6.12B2026-01-31: $6.87B$6.87B$0.00
1990-01-312026-01-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TJX operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 37 observations from Jan 31, 1990 to Jan 31, 2026.

TJX Companies Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
6,874,000,000
6,116,000,000
6,057,000,000
4,084,000,000
3,057,500,000
4,561,900,000
4,066,700,000
4,088,500,000
3,025,600,000
3,626,859,000
2,959,900,000
3,008,400,000
2,590,300,000
3,045,600,000
1,915,900,000
1,976,500,000
2,271,900,000
1,154,572,000
1,361,107,000
1,195,033,000
1,158,019,000
1,079,831,000
770,500,000
908,560,000
912,446,000
556,763,000
577,970,000
642,800,000
440,000,000
713,800,000
184,300,000
104,500,000
84,400,000
138,600,000
105,600,000
127,600,000
87,300,000

Compare operating cash flow (statement)

All TJX financial metrics · TJX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.